Filer Snapshot

David Apelian

CIK 0001546842. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

19

Latest filing

06 Jul 2023

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for EIGR. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 06 Jul 2023 for CIK 0001546842.

View source filing
Business address
C/O Achillion Pharmaceuticals, Inc, 300 George Street, New Haven, CT, 06511

Filer intelligence

What SEC filings say about David Apelian

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for EIGR.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

EIGR

03 Jul 2023 ยท CEO

Latest update

What changed recently for David Apelian

Ownership report updated

Latest ownership report period: 03 Jul 2023. Open the source-backed page to inspect the fresh filing or facts context.

Update date

06 Jul 2023

Page type

Ownership filings

Latest period

03 Jul 2023

Ownership context was refreshed from SEC Forms 3/4/5 filed on 06 Jul 2023.

SEC filing record

CIK 0001546842 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
19
First seen
30 May 2013
Latest filing
06 Jul 2023
Entity
Individual

Observed form types

4 3 4/A

Latest Filings

Showing the latest 12 of 19 SEC filings for David Apelian.

4 File 001-36183

4 filing

Filing date
06 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4

Filing date
02 Feb 2023
Reporting date
31 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4

Filing date
18 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4

Filing date
11 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
15 Mar 2021
Reporting date
12 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
26 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
16 Mar 2018
Reporting date
14 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
09 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-36183

FORM 4 SUBMISSION

Filing date
06 Oct 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36183

FORM 3 SUBMISSION

Filing date
20 Jun 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33095

FORM 4 SUBMISSION

Filing date
19 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .